Murine lymphocytes from spleen, lymph node, and thymus were examined for IgM complex receptors. Lymphocytes from all three organs were found to bind SRBC sensitized with IgM from various sources including: primary anti SRBC serum, murine and rabbit anti Escherichia coli LPS sera, and a murine IgM myeloma (MOPC 104E). Rosette formation by lymphocytes with IgM sensitized SRBC was inhibited by soluble antigen IgM complexes but not by IgM or antigen alone. Rosette formation was also inhibited by human IgM (Fc) 5(μ) but not by Fabμ. Antiserum and complement treatment of the cells and subsequent recovery of the viable cells by trypsinization, filtration, and washing revealed the IgM rosette forming cell (RFC) in the thymus to be a T cell. Spleen on the other hand was found to contain both B and T cells capable of binding IgM sensitized SRBC. Removal of both B and T cells from spleen cell suspensions eliminated all IgM RFC. The IgM complex receptor was found to be trypsin insensitive. Anti Ig column fractionation enriched IgM RFC in spleen and lymph node suspensions passed through the columns, whereas cell bearing surface Ig, IgG complex receptors, and C3 receptors were retained in the columns.